BSECompany Update1d ago · 14 Oct 2026, 05:11 pm

Submission of Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015, for service agreement entered into with Franchise India Brands Limited.

Abate As Industries Ltd · 531658

✦ AI SummaryOrder Win

Abate As Industries Ltd has entered into a Franchise Development Program, Representation & Recruitment Services Agreement with Franchise India Brands Limited for expansion of the Company's eye hospital business under the brand name 'ABATE EYE HOSPITAL' through the franchise model across India.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Abate As Industries Ltd - 531658 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Attachments (1)

📄

58c919d7-edd3-4c4f-8b0d-352f0e6045c5.pdf

pdf

Download →
View document text
CIN: L65990TZ1991PLC029162 Date: 14.10.2026 The Manager Listing Compliance Department BSE Limited⁠ Scrip Code: 531658 Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for service agreement entered with Franchise India Brands Limited With reference to the captioned subject and pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Company has entered into a Franchise Development Program, Representation & Recruitment Services Agreement with Franchise India Brands Limited effective from October 14, 2026 for expansion of the Company's eye hospital business under the brand name "ABATE EYE HOSPITAL" through the franchise model across India. The details in this regard, pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD-PoD2/CIR/P/0155 dated November 11, 2024 updated circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, is enclosed herewith as Annexure - A. The disclosure is being made in the interest of good corporate governance and investor awareness. This is for your information and records. For ABATE AS Industries Limited Heena Kausar Rangari Company Secretary & Compliance Officer CIN: L65990TZ1991PLC029162 Annexure A The details as required under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”) read with the SEBI Master Circular No. SEBI/HO/CFD-PoD2/CIR/P/0155 dated November 11, 2024: Sr. Particulars Details 1 Name(s) of parties with whom the agreement is Franchise India Brands Limited entered 2 Purpose of entering into the agreement Franchise Development Program, Representation & Recruitment Services Agreement for development of franchise systems, franchise documentation, lead generation, representation and recruitment of franchise partners for expansion of ABATE Eye Hospital across India. 3 Size of agreement INR 30,00,000/- (Indian Rupees Thirty Lakhs Only) 4 Shareholding, if any, in the entity with whom the NIL agreement is executed 5 Significant terms of the agreement (in brief) Term of Agreement: special rights like right to appoint directors, 24 months from the effective first right to share subscription in case of issuance date. of shares, right to restrict any change in capital As per the terms and structure etc. conditions agreed between the parties, including fixed consultancy fees and success- based fees linked to franchise acquisitions. 6 Whether, the said parties are related to No promoter/promoter group/ group companies in CIN: L65990TZ1991PLC029162 any manner. If yes, nature of relationship 7 Whether the transaction would fall within related The transaction is not a related party transactions? If yes, whether the same is party transaction done at “arm’s length”. 8 In case of loan agreements, details of NA lender/borrower, nature of the loan, total amount of loan granted/taken, total amount outstanding, date of execution of the loan agreement/sanction letter, details of the security provided to the lenders / by the borrowers for such loan or in case outstanding loans lent to a party or borrowed from a party become material on a cumulative basis 9 In case of issuance of shares to the parties, NA details of issue price, class of shares issued 10 Any other disclosures related to such agreements, NA viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc. 11 In case of termination or amendment of agreement, NA listed entity shall disclose additional details to the stock exchange(s): a) name of parties to the agreement; b.) nature of the agreement; c.) date of execution of the agreement; d.) details of amendment and impact thereof or reasons of termination and impact thereof.